Education
About Us
Working with TipRanks
Follow Us
Christopher Bryan Insider Profile
4 Followers
Christopher Bryan, Vice-President Research & Operations at Algernon Pharmaceuticals, holds 80.50K shares in Algernon Pharmaceuticals (Ticker: AGNPF). Most recently, Christopher Bryan ― shares of Algernon Pharmaceuticals on ― for an estimated value of ―.
Christopher Bryan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Bryan's holdings
Insider Roles
Vice-President Research & Operations
Roles that Christopher Bryan holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christopher Bryan
Christopher Bryan's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Bryan's performance on stock
You May Also Like
Christopher Bryan insider profile FAQ
What is the percentage of profitable transactions made by Christopher Bryan?
The percentage of profitable transactions made by Christopher Bryan is ―.
What is the average return per transaction made by Christopher Bryan?
The average return per transaction made by Christopher Bryan is ―.
What stocks does Christopher Bryan hold?
Christopher Bryan holds: AGNPF stocks.
What was Christopher Bryan’s latest transaction?
Christopher Bryan latest transaction was an Uninformative Buy of ―.
What was Christopher Bryan's most profitable transaction?
Christopher Bryan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christopher Bryan's role in Algernon Pharmaceuticals?
Christopher Bryan's role in Algernon Pharmaceuticals is Vice-President Research & Operations.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.